Back to Search
Start Over
Therapeutic Dose of Amitriptyline for Older Patients with Burning Mouth Syndrome
- Source :
- Neuropsychiatric Disease and Treatment, Vol Volume 15, Pp 3599-3607 (2019)
- Publication Year :
- 2019
- Publisher :
- Dove Medical Press, 2019.
-
Abstract
- Takayuki Suga,1 Miho Takenoshita,1 Takeshi Watanabe,1 Trang TH Tu,1 Lou Mikuzuki,1 Chaoli Hong,1 Kazuhito Miura,2 Tatsuya Yoshikawa,1 Takahiko Nagamine,3 Akira Toyofuku1 1Department of Psychosomatic Dentistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan; 2Department of Gerodontology, Division of Oral Health Science, Graduate School of Dental Medicine, Hokkaido University, Hokkaido, Japan; 3Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, Yamaguchi, JapanCorrespondence: Akira ToyofukuDepartment of Psychosomatic Dentistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo 113-8510, JapanTel/Fax +81 3 5803 5898Email toyoompm@tmd.ac.jpObjective: To assess the therapeutic dose and safety of amitriptyline and the outcome following treatment with amitriptyline among older patients with burning mouth syndrome (BMS).Methods: 187 consecutive patients were prescribed amitriptyline as a first-line medication from April 2016 to September 2018 and followed-up for >1 month. Patients were divided into 3 groups: group 1, 113 patients aged
Details
- Language :
- English
- ISSN :
- 11782021
- Volume :
- ume 15
- Database :
- Directory of Open Access Journals
- Journal :
- Neuropsychiatric Disease and Treatment
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.72ddda0f4b9fb106bc5f474e836e
- Document Type :
- article